Richard A. Sachson, MD, FACP, FACE

- Board Certification from the American Board of Internal Medicine (ABIM)
- Subspecialty Board Certification of Endocrinology, Diabetes, & Metabolism
Dr Richard A. Sachson practices endocrinology, diabetes and metabolism in Dallas, TX. Listed as a Texas Monthly Super Doc for many years, Dr Sachson is the managing partner of Endocrine Associates of Dallas. He is the director of the endocrine division at Texas Health Presbyterian hospital, Dallas and the former medical director of the Diabetes Management Institute, St Paul Hospital, Dallas, TX.
Endocrine Associates of Dallas & Plano
Dallas Office (Only)
10260 North Central Expressway, Suite 100N, Dallas, Texas 75231
214-363-5535
214-368-2760 Fax
EAD Dallas Office Hours
Monday – Friday: 8:00 AM – 4:00 PM
Voted Best Doctor by his peers in D Magazine every year from the accolade’s inception.
Biography
Richard A. Sachson, MD, FACP, FACE – Biography
Richard A. Sachson, M.D., received his Bachelor of Science Degree from Brooklyn College, Brooklyn, New York in 1964, and his M.D. (summa cum laude) in 1968 from the State University of New York, Downstate Medical Center, Brooklyn, New York. He then completed a year as a guest investigator at Rockefeller University in New York City. Dr. Sachson did his internship and residency from 1968-1970 with the Department of Internal Medicine, University of Chicago Hospitals, Chicago, Illinois. He also did two years of fellowship with a Clinical Association with the National Institutes of Health, NIAMD, Bethesda, Maryland, and an additional two years as a Clinical Research Fellow, Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts.
Dr. Sachson has been a Clinical Endocrinologist with Endocrine Associates of Dallas, P.A., since 1974 and is an investigator, subinvestigator and Partner Advisor for Research Institute of Dallas. He is also a Clinical Professor of Medicine at the University of Texas Southwestern Medical Center at Dallas and an attending physician at Presbyterian Hospital of Dallas.
In addition, he is the Medical Director of the Diabetes Management Institute and an attending physician at St. Paul Hospital in Dallas. Dr. Sachson is board certified in Endocrinology and Metabolism subspecialty by the American Board of Internal Medicine. He is a Fellow of the American College of Physicians and the American College of Endocrinology as well as a member of the Endocrine Society and the American Association of Clinical Endocrinologists. Dr. Sachson has been a lead or contributing author on numerous research publications and has held positions as an officer, board member or committee member with many medical professional and research organizations.
Curriculum Vitae
Richard A. Sachson, MD, FACP, FACE – Curriculum Vitae
Positions and Employment:
- 1967-1968 – Guest Investigator, Rockefeller University, New York, N.Y.
- 1970-1972 – Clinical Associate, National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md.
- 1972-1974 – Clinical research fellow, endocrine unit, Massachusetts General Hospital, Boston, Ma.
- 1972-1974 – Clinical Instructor in Medicine, Harvard University, Boston, Ma.
- 1974 – Endocrinologist, Endocrine Associates of Dallas, Dallas, Tx.
- 1974-1980 – Clinical Assistant Professor of Medicine, University of Texas, Southwestern Medical Center, Dallas, Tx.
- 1980-1991 – Clinical Associate Professor of Medicine, University of Texas, Southwestern Medical Center, Dallas, Tx.
- 1991 – Clinical Professor of Medicine, University of Texas, Southwestern Medical Center, Dallas, Tx.
Other Experience and Professional Memberships:
- 1973 – Board Certification American Board of Internal Medicine
- 1973 -Board Certification American Board of Endocrinology and Metabolism
- 1974 – Endocrine Society
- 1974 – Fellow, American College of Physicians
- 1974 – American Medical Association
- 1974 – American Diabetes Association
- 1974 – Texas Medical Association
- 1974 – Dallas County Medical Society
- 1974-2004 – Attending Physician, St Paul Hospital, Dallas, Tx.
- 1974 – Attending Physician, Presbyterian Hospital of Dallas
- 1979-1980 – President, Dallas Internists Club
- 1980-1996 – Medical Director, Diabetes Management Institute, St Paul Hospital, Dallas, Tx.
- 1980-1996 – Board of Directors, Dallas Chapter, American Diabetes Association
- 1982-1989 – Board of Directors, Texas Affiliate, American Diabetes Association
- 1983-1986 – Vice-president, Texas Affiliate, American Diabetes Association
- 1986-1988 – President, Texas Affiliate, American Diabetes Association
- 1984-2008 – Chairman, Pharmacy and Therapeutics Committee, Presbyterian Hospital of Dallas
- 1984 – Founding Editor, Pharmacy Newsletter, Presbyterian Hospital of Dallas
- 1985-1987 – Medical Advisory Board, Juvenile Diabetes Foundation, Dallas, Tx.
- 1985-1987 – Board of Directors, Texas Endocrine and Diabetes Association
- 1988-1991 – National Board of Directors, American Diabetes Association
- 1989-1991 – Professional Practice Committee, American Diabetes Association
- 1991 – American Association of Clinical Endocrinologists
- 1992 – Fellow, American Association of Clinical Endocrinologists
- 1991-1992 – Vice-chairman, Professional Membership Taskforce, American Diabetes Association
- 1992-1993 – National Faculty Member, Clinical Education Program III, American Diabetes Association
- 1993-1995 – Editorial Board, “Clinical Diabetes”
- 1993-1996 – Clinical Endocrinology Initiatives Committee, Endocrine Society
- 1997-2004 – Director, Endocrine Division, St Paul Hospital , Dallas, Tx.
- 1997 -Director, Endocrine Division, Presbyterian Hospital, Dallas, Tx.
Honors
- 1968 – M.D. Summa Cum Laude, S.U.N.Y. Downstate Medical Center, Brooklyn, N.Y.
- 1967 – Alpha Omega Alpha honor medical society, S.U.N.Y. Downstate Medical Center, Brooklyn, N.Y.
- 1970 – Hilger Perry Jenkins teaching award, University of Chicago Hospitals, Chicago , Ill.
Military service
Lieutenant Commander United States Public Health Service, National Institutes of Health
Professional Experience
Co-Founder and partner of Endocrine Associates of Dallas, 1974-present
Research Experience
Guest investigator, Rockefeller University 1968 Clinical Associate, National Institute of Arthritis and Metabolic Disease, National Institutes of Health 1970-1972 Principal Investigator, research institute of Dallas 1980-present
Faculty appointment
Clinical Professor of Medicine at the University of Texas, Southwestern Medical Center
Bibliography
Bibliography
Peer-reviewed Publications
- Sachson,R.A.,Song,C.S.,Levere,R.D.,and Kappas,A. (1968). Steroid Induction of Hepatic delta-Aminolevulinic Acid Synthase in Vivo in the Chick Embryo. Clinical Research 26:351 (Abstract)
- Kappas,A., Song,C., Levere, R.D., Sachson,R.A., and Granick,S. (1968). The Induction of delta-Aminolevlinic Acid Synthase in Vivo in the Chick Embryo Liver by Natural Steroids. Proc. Nat. Acad. Sci. 61:509-513.
- Sachson,R.A., Rosen,S.W., Cuatrecasas,P., Roth,J.,and ,Frantz,A.G. (1972). Prolactin Response to TSH- Releasing Hormone in TSH Deficiency. New Eng. J. Med 287:972-973.
- Hudgins,R.,Raney,L.A., Young,S.W., and Sachson,R.A. (1981). Failure of Intrasellar Muscle Implants to Prevent Recurrent Downward Migration of the Optic Chiasm. Neurosurgery 8:231-232.
- Dorfman,S., Sachson,R.A., and Feld,S. (1982). The Rationale for Treatment of Lymphocitic Thyroiditis with Spontaneously Resolving Hyperthyroidism (1982). Arch Int. Med. 142:2261-2262. (Editorial)
- Dorfman,S.G., Feld,S., Sachson,R.A., and Aronoff,S.A. (1985). Antithyrioid Drugs: Propylthiouracil versus Methimazole. Dallas County Medical Society Journal. 71:91-95.
- Sachson, R.A., Feld,S., Dorfman,S.G., and Aronoff, S. (1990). Osteoporosis and the Spine in Sports: The Benefits of Exercise in the Spine in Sports. Mosby Year Book.
- Goldberg,A., Alagona,P., Capuzzi,D., Guyton,J., Morgan,J., Rodgers,I., Sachson,R., and Samuel,P. (2000). Multiple Dose Efficacy and Safety of an Extended Release Form of Niacin in the Management of Hyperlipidemia (2000). American Journal of Cardiology 85:1100-1105.
- Malone,J., Kerr,L., Campaigne,B., Sachson,R., and Holcombe,J. (2004). Combined Therapy with Insulin Lispro Mix 75/25 Plus Metformin or Insulin Glargine Plus Metformin: A 16 Week, Randomized, Open-Label, Crossover Study in Patients with Type 2 Diabetes Beginning Insulin Therapy. (2004). Clinical Therapeutics. 26:2034-2044.
- Hardey,T., Sachson,R., Shuyi,S., Armbruster,M., and Boulton,A. (2007) Does Treatment With Duloxetine for Neuropathic Pain Impact Glycemic Control? Diabetes Care 30:21-26.
- Ram,C., Sachson, R, Littlejohn,T, Qian,C, Shojaer,A, Stoakes,K, and Nuetel,J.( 2011 ). Management of Hypertension in Patients with Diabetes Using an Amlodipine-,Olmesartan Medoximil-, and Hydrochlorothiazide- based Titration Regimen. Am. J. Cardiology 107: 1346-1352.
